Cutler Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-33
| Closed | – | – | 1999 |
|
2023
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 2121 |
|
2023
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 2133 |
|
2023
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 2129 |
|
2023
Q1 | $0 | Sell |
33
-4
| -11% | – | ﹤0.01% | 2367 |
|
2022
Q4 | $1K | Buy |
37
+7
| +23% | +$189 | ﹤0.01% | 1674 |
|
2022
Q3 | $6K | Buy |
+30
| New | +$6K | ﹤0.01% | 1530 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 2610 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 2740 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 2899 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 2860 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 2805 |
|
2020
Q4 | – | Sell |
-103
| Closed | -$25K | – | 2507 |
|
2020
Q3 | $25K | Buy |
+103
| New | +$25K | ﹤0.01% | 1092 |
|
2017
Q2 | – | Sell |
-38
| Closed | -$12K | – | 3435 |
|
2017
Q1 | $12K | Hold |
38
| – | – | ﹤0.01% | 2074 |
|
2016
Q4 | $13K | Hold |
38
| – | – | ﹤0.01% | 2110 |
|
2016
Q3 | $15K | Sell |
38
-2
| -5% | -$789 | ﹤0.01% | 1958 |
|
2016
Q2 | $23K | Hold |
40
| – | – | ﹤0.01% | 1757 |
|
2016
Q1 | $19K | Hold |
40
| – | – | ﹤0.01% | 1755 |
|
2015
Q4 | $26K | Buy |
+40
| New | +$26K | ﹤0.01% | 1732 |
|